Earnings NewsHealthcareRecro Pharma GAAP EPS of $0.04 beats by $0.11, revenue of $22.3M beats by $0.89MMar. 01, 2022 4:14 PM ETSocietal CDMO, Inc. (SCTL)By: Urvi Shah, SA News Editor Recro Pharma press release (NASDAQ:REPH): Q4 GAAP EPS of $0.04 beats by $0.11. Revenue of $22.3M (+125.0% Y/Y) beats by $0.89M. Recommended For YouCommentsNewestPublishHave a tip? Submit confidentially to our News team. Found a factual error? Report here.More Trending NewsBitcoin rally bodes well for miners’ profit prospectsU.S. makes COP28 splash with new methane rule, $3B pledge to help countries cut emissionsNotable earnings before Monday's openPlug Power surges to top industrial gainer of week, Kanzhun sees No. 1 loser tagCrypto-tied stocks top financial gainers for second straight weekSee More »About SCTLSymbolLast Price% Chg1D5D1M6M1Y5Y10YMarket CapPEYield (TTM)Rev Growth (YoY)Short InterestPrev. CloseCompare to PeersRelated StocksSymbolLast Price% ChgSCTL--Societal CDMO, Inc.SHWZ--Medicine Man Technologies, Inc.RAIN--Rain Oncology Inc.SLGL--Sol-Gel Technologies Ltd.GDNSF--Goodness Growth Holdings, Inc.CompareTrending AnalysisTrending News